• Acute Hepatitis Panel
  • Cannabinoid, Urine
  • Erythropoietin
  • Influenza Virus Type A and B, SARS-CoV-2 (COVID-19) Antibody or Antigen
  • Amyotrophic Lateral Sclerosis Gene Mutation Panel, NGS
  • Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis
  • Cyclin-Dependent Kinase-Like 5 (CDKL5) Mutation Analysis
  • Vanillylmandelic Acid (VMA), Random, Urine
  • Bordetella pertussis and Bordetella parapertussis, Molecular
  • Trypanosoma cruzi (T. cruzi) Antibody, IgG and IgM
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Multiple Sulfatase Deficiency, Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Multiple Sulfatase Deficiency, Gene Mutation Analysis
Medical Test

ICD10
Access to Multiple Sulfatase Deficiency, Gene Mutation Analysis is restricted.